Semmelweis University, Department of Ophthalmology
Budapest, 1085, Hungary
NCT Number: NCT03357146
Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery occlusion with non-invasive, non-contact optical coherence tomography angiography.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Budapest, 1085, Hungary
Occlusion of the retinal arteries is an emergency which causes sudden, painless unilateral vision loss. Loss of blood flow causes ischemic damage to the retina. The extent of damage depends on the area affected.
Following the acute phase of the disease re-canalization occurs and lesser blood flow can be detected usually without functional recovery.
Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery occlusion.
Standard procedures to examine this disease include retinoscopy following pupil dilation, fluorescein angiography and more recently, optical coherence tomography (OCT).
The latest direction in OCT development was OCT angiography (OCTA) which is a software upgrade that allows detection of blood flow based on motion contrast. Similar to previous OCT machines OCTA is also non-invasive and non-contact and does not require any intravenous agents.
OCT machines are approved in the EU and the US and are not experimental devices.
The device used in this study is the commercially available Zeiss Cirrus HD OCT Angioplex 5000 that operates with spectral-domain technology.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
OCTA scans per built-in device protocol
Time frame: Through study completion, 1 year
Time frame: Through study completion, 1 year
Semmelweis University
Other
Acronym: RAO-OCTA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03313817
Arterial Occlusive Diseases, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT03753893
Amaurosis Fugax, Arterial Occlusive Diseases
View Trial DetailsNCT04723160
Arterial Occlusive Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT02679716
Arterial Occlusive Diseases, Cardiovascular Diseases
Vienna, Austria
View Trial Details